Skip to content
Disclosery

ACCIPITER CAPITAL MANAGEMENT, LLC

Follow

13F filer, CIK 1280190, Jersey City, NJ

ACCIPITER CAPITAL MANAGEMENT, LLC reported $49,189,000 across 3 holdings for the quarter ended 2017-12-31, in a 13F-HR filed 2018-02-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000921895-18-000672

Period
2017-12-31
Reported value
$49.2M
Holdings
3
Top 10 weight
100%
New
0
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
SHIRE PLCadded+12,738$1.98M
FORESIGHT ENERGY LPadded+9,832$43K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
TEVAreduced-180,121-$3.41M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2017

Share positions as resolved from 13F-HR 0000921895-18-000672, largest first. % of portfolio is the value over $49,189,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
FORESIGHT ENERGY LPFORESIGHT ENERGY LPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q1: restricted; 2016Q2: restricted; 2016Q3: restricted; 2016Q4: 7,836,251 shares; 2017Q1: 7,622,302 shares; 2017Q2: 7,622,302 shares; 2017Q3: 7,623,702 shares; 2017Q4: 7,633,534 shares 7,633,534$33.4M67.82%+9,832
TEVATEVA PHARMACEUTICAL INDS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q1: restricted; 2016Q2: restricted; 2016Q3: restricted; 2016Q4: 204,030 shares; 2017Q1: 200,000 shares; 2017Q2: 202,145 shares; 2017Q3: 604,185 shares; 2017Q4: 424,064 shares 424,064$8.04M16.34%-180,121Timeline
SHIRE PLCSHIRE PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q1: restricted; 2016Q2: restricted; 2016Q3: restricted; 2016Q4: not reported; 2017Q1: 24,578 shares; 2017Q2: 24,578 shares; 2017Q3: 37,505 shares; 2017Q4: 50,243 shares 50,243$7.79M15.85%+12,738

How Q4 2017 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000921895-18-000672 base2018-02-14acceptance time not in the bulk data set